Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
Journal of Human Genetics|December 9, 2016
Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancerIvana Antonucci, Martina Provenzano, Luca Sorino, et al.Journal of Experimental & Clinical Cancer Research : CR|September 23, 2018
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsSerena Veschi, Laura De Lellis, Rosalba Florio, et al.Cells|August 7, 2021
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant SettingAntonino Grassadonia, Vincenzo Graziano, Laura Iezzi, et al.Cancer Research|August 24, 2016
Interleukin-30 Promotes Breast Cancer Growth and ProgressionIrma Airoldi, Claudia Cocco, Carlo Sorrentino, et al.Recenti Progressi in Medicina|December 28, 2020
Long-term outcome of pemetrexed maintenance for advanced nonsquamous non-small-cell lung cancer: a real-world observational cohort studyFabrizio Nelli, Maria Agnese Fabbri, Luca Moscetti, et al.Breast (Edinburgh, Scotland)|January 9, 2017
Long-term outcome of breast cancer patients with pathologic N3a lymph node stageAntonino Grassadonia, Patrizia Vici, Teresa Gamucci, et al.Anticancer Research|April 1, 2009
Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosisIda Iurisci, Albana Cumashi, Andrei A Sherman, et al.Journal of Clinical Medicine|December 15, 2018
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical TrialsAntonino Grassadonia, Isabella Sperduti, Patrizia Vici, et al.Therapeutic Advances in Medical Oncology|August 28, 2020
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI scoreAntonio Galvano, Marta Peri, Aurelia Ada Guarini, et al.Molecular Cancer Therapeutics|February 21, 2014
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibodySara Traini, Enza Piccolo, Nicola Tinari, et al.Pageof 10